Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design
{{output}}
Background: HIV-1 integrase is a clinically validated therapeutic target for the treatment of HIV-1 infection, with one approved therapeutic currently on the market. This enzyme represents an attractive target for the development... ...
